Voiding Efficiency, a Predictor of Clean Intermittent Catheterization (CIC)



Status:Active, not recruiting
Conditions:Overactive Bladder
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:18 - Any
Updated:2/27/2019
Start Date:May 12, 2017
End Date:June 30, 2019

Use our guide to learn which trials are right for you!

Voiding Efficiency, a Predictor of CIC

This study is a retrospective chart review of patients treated with onabotulinumtoxinA
(BOTOX®) for idiopathic overactive bladder (OAB) and will determine voiding efficiency (VE)
cutoff ratios that predict post-procedure urinary retention requiring catheterization.


Inclusion Criteria:

- Patient with documented idiopathic OAB diagnosis

- Patient was treated with 100-200U of BOTOX® for OAB

- Urodynamics assessment within prior to first BOTOX® injection.

Exclusion Criteria:

- Patient had received botulinum toxin formulations other than BOTOX® in the bladder

- Patient had symptoms of OAB associated with a neurological condition (eg, spinal cord
injury, multiple sclerosis, cerebrovascular accident, Alzheimer's disease, Parkinson's
disease, etc).
We found this trial at
3
sites
Shreveport, Louisiana 71106
?
mi
from
Shreveport, LA
Click here to add this to my saved trials
Baltimore, Maryland 21204
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Richmond, Virginia 23235
?
mi
from
Richmond, VA
Click here to add this to my saved trials